Quarterly report · Q3
6856.TEDINET S100SA9K
Period2023-01-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥200.7bn | 2023-01-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥270.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥185.1bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥28.5bn | 2023-01-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥28.6bn | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥29.1bn | 2023-01-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥46.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥29.5bn | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥35.6bn | 2023-01-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥29.9bn | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥27.0bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20.7bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥27.0bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥20.7bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥441.3bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥416.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥402.3bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥166.6bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥175.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥274.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥240.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥233.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥126.7bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥139.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥638.32 | 2023-01-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥188.45 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥807.06 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥490.4 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥224.09 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥635.22 | 2023-01-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥802.89 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥487.86 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 62.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥48.2bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥48.2bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥2.7bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥23.4bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥23.4bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥229m |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥17.3bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥17.3bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥1.4bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥27.3bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥27.3bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥762m |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥84.6bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥84.6bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥28.8bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥41.3bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥41.3bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥3.3bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥21.6bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥21.6bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥21m |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥15.4bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥15.4bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥981m |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥25.4bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥25.4bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥81.4bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥81.4bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥29.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 402
| Item | Context | Value | Unit |
|---|---|---|---|
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |